TRAPS: Therapeutic Response Analysis via Pathway-informed Stratification

In three linesUnified benchmark for cancer therapy response prediction using pathway-informed deep learning architectures (BINN, GraphPath, PATH). Evaluation on 2,622 patients from The Cancer Genome Atlas across three clinical tasks: targeted molecular therapy, radiation therapy, and 6-month survival. GraphPath achieves AUROC 0.92 on prostate targeted therapy prediction.

Summary generated by Claude — human-verified